source
- A year after Vertex’s big launch, pain drug research faces a pivotal momentJournavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?BioPharma Dive · 2mo ago↗ source
- STAT+: Trump pivots on kratom derivative 7-OH, floating approval for some formsLast year, the FDA had warned that natural opioids in kratom were being turned into harmful products. Now President Trump says approval should be considered.STAT · 2mo ago↗ source
- Dr Randall on the Rationale for Investigating CSF-1R Inhibition in TGCTR. Lor Randall, MD, FACS discusses safety and efficacy data from the MANEUVER trial, which evaluated pimicotinib in TGCT.onclive · 2mo ago